Verve Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Verve Therapeutics details its financial performance for 2024 and offers updates on its gene editing programs targeting cardiovascular disease.
Verve Therapeutics updates its employment agreement with its Chief Scientific Officer and files its annual report on Form 10-K, detailing its financial performance and clinical trial progress.